Your institution may have access to this item. Find your institution then sign in to continue.
Title
'Little Quality Evidence' for Marketing MRT as Fertility Treatment.
Abstract
The article presents insights from several bioethicists including Jeffrey Kahn of Johns Hopkins Berman Institute of Bioethics and Ainsley Newson of the University of Sidney regarding issues against the commercialization of mitochondrial replacement therapy (MRT).